Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Ganirelix

Name
Ganirelix
Molecular structural formula
Purity
95%
CAS Number
123246-29-7
Formula
C80H113ClN18O13
MW
1570.32
Target
GnRH Receptor
Sequence
Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Tyr-D-{Har(Et,Et)}-Leu-{Har(Et,Et)}-Pro-D-Ala-NH2
Sequence Shortening
Ac-{D-2Nal}-{D-Phe(4-Cl)}-{D-3Pal}-SY-{D-Har(Et,Et)}-L-{Har(Et,Et)}-P-{D-Ala}-NH2
InChIKey
GJNXBNATEDXMAK-PFLSVRRQSA-N
References
[1]. Gillies PS, et al. Ganirelix. Drugs. 2000 Jan;59(1):107-11; discussion 112-3. [2]. Russo A, et al. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats. Eur Urol. 2011 May;59(5):868-74.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone relea